Table 3. Number of deaths ( n ) and age-standardized a all-cause mortality rates per 1,000 population during intervals of 30, 90, and 180 days after incident VTE diagnosis and cumulatively during the surveillance period April 1, 2012 through March 31, 2014 .
Demographic | 0–30 d | 31–90 d | 91–180 d | >180 d | Cumulative | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | Rate | 95% CI | n | Rate | 95% CI | n | Rate | 95% CI | n | Rate | 95% CI | N | Rate | 95% CI | |
Overall | 460 | 0.339 | 0.309–0.371 | 198 | 0.146 | 0.127–0.168 | 149 | 0.110 | 0.94–0.129 | 279 | 0.207 | 0.184–0.232 | 1,086 | 0.801 | 0.755–0.850 |
Age | |||||||||||||||
< 18 | 1 | 0.003 | 0.000–0.018 | 2 | 0.005 | 0.001–0.021 | 0 | 0 | – | 0 | 0 | – | 3 | 0.008 | 0.003–0.024 |
≥ 18 | 459 | 0.408 | 0.371–0.447 | 196 | 0.174 | 0.151–0.200 | 149 | 0.132 | 0.113–0.155 | 279 | 0.248 | 0.220–0.279 | 1,083 | 0.962 | 0.906–1.021 |
18–39 | 21 | 0.044 | 0.028–0.067 | 6 | 0.012 | 0.006–0.028 | 4 | 0.008 | 0.003–0.022 | 6 | 0.012 | 0.006–0.028 | 37 | 0.077 | 0.056–0.106 |
40–49 | 24 | 0.133 | 0.089–0.198 | 13 | 0.072 | 0.042–0.124 | 5 | 0.028 | 0.012–0.225 | 17 | 0.094 | 0.059–0.152 | 59 | 0.327 | 0.253–0.422 |
50–59 | 65 | 0.331 | 0.260–0.422 | 23 | 0.117 | 0.078–0.176 | 31 | 0.158 | 0.111–0.225 | 44 | 0.224 | 0.167–0.301 | 163 | 0.831 | 0.712–0.968 |
60–69 | 103 | 0.728 | 0.600–0.883 | 39 | 0.276 | 0.201–0.377 | 25 | 0.177 | 0.119–0.262 | 58 | 0.410 | 0.317–0.530 | 225 | 1.590 | 1.396–1.812 |
70–79 | 93 | 1.236 | 1.008–1.514 | 58 | 0.771 | 0.596–0.997 | 34 | 0.452 | 0.323–0.632 | 56 | 0.744 | 0.573–0.967 | 241 | 3.202 | 2.822–3.632 |
≥ 80 | 153 | 3.073 | 2.623–3.601 | 57 | 1.145 | 0.883–1.484 | 50 | 1.004 | 0.761–1.325 | 98 | 1.969 | 1.615–2.400 | 358 | 7.191 | 6.483–7.976 |
Sex | |||||||||||||||
Male | 218 | 0.334 | 0.292–0.381 | 94 | 0.145 | 0.118–0.177 | 81 | 0.123 | 0.010–0.153 | 130 | 0.200 | 0.168–0.238 | 523 | 0.082 | 0.736–0.873 |
Female | 242 | 0.345 | 0.304–0.391 | 104 | 0.148 | 0.122–0.180 | 68 | 0.098 | 0.077–0.125 | 149 | 0.214 | 0.182–0.251 | 563 | 0.805 | 0.741–0.874 |
Race/ethnicity | |||||||||||||||
Asian/Pacific Islander | 5 | 0.121 | 0.049–0.296 | 4 | 0.080 | 0.030–0.213 | 0 | 0 | – | 2 | 0.048 | 0.012–0.194 | 11 | 0.248 | 0.136–0.453 |
Non-Hispanic black | 77 | 0.355 | 0.284–0.445 | 47 | 0.215 | 0.161–0.286 | 31 | 0.145 | 0.102–0.206 | 50 | 0.224 | 0.169–0.295 | 205 | 0.938 | 0.818–1.077 |
Hispanic | 15 | 0.111 | 0.065–0.190 | 4 | 0.023 | 0.008–0.065 | 4 | 0.034 | 0.012–0.096 | 8 | 0.061 | 0.029–0.125 | 31 | 0.229 | 0.158–0.332 |
Native American | 10 | 0.195 | 0.105–0.363 | 4 | 0.072 | 0.027–0.194 | 2 | 0.036 | 0.009–0.145 | 7 | 0.133 | 0.063–0.279 | 23 | 0.437 | 0.290–0.658 |
Non-Hispanic white | 346 | 0.396 | 0.357–0.441 | 135 | 0.156 | 0.132–0.185 | 107 | 0.123 | 0.102–0.149 | 203 | 0.235 | 0.204–0.269 | 791 | 0.910 | 0.849–0.976 |
Abbreviations: CI, Confidence interval; VTE, venous thromboembolism.
Overall, sex-stratified, and race/ethnicity-stratified results are standardized to the 2013 U.S. population.